Hematological and Oncology Flashcards
SICKLE CELL ANEMIA
Sickle cell anemia is an inherited disorder that affects the shape of red blood cells.
Sickle cell anemia affects approximately 100,000 individuals in the U.S (CDC, 2019). The disease primarily affects African Americans, but can also affect other individuals from Mediterranean countries.
In the African American population, 1 in 365 African American infants will have sickle cell disease and 1 in 13 will have the trait (CDC, 2019).
Sickle Cell
Individuals with sickle cell inherit the HbS gene from both parents. HbS causes the RBC to have a sickle shape, which alters the transport of oxygen and movement of RBC.
RBC are often clustered together causing vaso-occlusion. Individuals present with following symptoms: pain (primarily in the joints), generalized fatigue, fever, swelling to hands, and feet, tachypnea, priapism (in males) GI symptoms (nausea, vomiting, and abdominal pain). Physical assessment may reveal hepatomegaly and splenomegaly.
Sickle cell anemia
affects several lab values.
Hemoglobin decreased
Hematocrit levels 20-30%
Reticulocyte count elevation
WBC elevation
Peripheral blood smear will show sickle shaped cells
Liver enzymes have the potential to be elevate
** Hemoglobin electrophoresis confirms the diagnosis.
Additional diagnostics: Joint x-rays, CT, MRI, blood cultures, and CBC.
Oxygen therapy required for patients with hypoxia.
In some instances, individuals may require blood transfusions. The following represent some factors that may warrant transfusion: symptomatic/recurrent anemia, sepsis, pre-operative treatment, and chronic hypoxia (Barkley, 2021).
Care for sickle cell patients also includes education on crisis prevention. Individuals should have yearly vaccinations for flu and pneumonia. It is common for individuals to take folic acid on a daily basis. Regular physical exams and family planning counseling is also necessary.
MANAGEMENT of Sickle Cell
The mainstay of treatment in sickle cell crisis include pain medications, IV fluids, and supplemental oxygen. Opioid medications (IV/PO) are used in the outpatient and inpatient setting to control pain during crisis. Medications that are used include: Morphine and Dilaudid. If the pain is not severe, NSAIDS maybe used to control pain. Ensure the patient is properly hydrated, NS bolus. Patients who exhibit symptoms of dehydration without hypovolemic shock NS or Lactated Ringers up to 1 liter ( Barkley, 2021). 1/2 NS is used with ongoing therapy
LEUKEMIA
Leukemia is a form of cancer that develops in the bone marrow.
The hematopoietic cells are altered which results in a decrease in normal blood cells. There are various types of leukemia, this sections will focus on ALL, AML, CML, and CLL.
The following are some symptoms associated with leukemia include: fatigue, bleeding gums, shortness of breath, pain (especially in joints and bones), fever, skin changes (petechia, ecchymosis), pale color, and lymphadenopathy (Barkley, 2021).
The individual maybe completely asymptomatic and some symptoms may or may not be present in the different types of leukemia.
Leukemia-diagnosis
Patient assessment findings and peripheral smears are used to diagnose leukemia.
Bone marrow aspiration/biopsy is needed to definitively diagnose leukemia.
The following are labs that appear abnormal:
WBC elevation
HGB, HCT, and platelets decreased
ESR elevation
Labs maybe variable depending on the type of leukemia.
Leukemia -Management
Individuals diagnosed with leukemia should be referred to an oncologist.
The management of leukemia is typically chemotherapy. Individuals may also undergo bone marrow transplantation.
Additional therapies include: IVF, blood transfusions, antibiotics for infections and allopurinol for patients who develop hyperuricemia.
ALL (Acute lymphocytic leukemia)
Typically occurs in children, but can occur in adults.
5-year survival rate in adults up to 40%
Greater than 30% lymphoblasts in bone marrow or blood.
Reciprocal translocation results in abnormal chromosome.
Occurs between chromosomes 9 and 22.
Hallmark: Pancytopenia with circulating blasts
Fatigue, fever, large/bleeding gums, lymphadenopathy, joint pain
Peripheral smear/Bone marrow aspiration/biopsy
Chemotherapy
Possible bone marrow transplant
AML (Acute myelogenous leukemia
Most common in adults
Remission rates up to 85%
Survival rates up to 40%
Abnormal proliferation of myeloid precursor cells
Decreased rate of apoptosis
Arrest in cellular differentiation
Mutation in the receptor tyrosine kinase FLT3
Ecchymosis, fever, fatigue
Peripheral smear/Bone marrow aspiration/ biopsy
Chemotherapy
CML (Chronic myelogenous leukemia)
A myeloproliferative disorder that also includes polycythemia vera, primary thrombocytosis, and idiopathic myelofibrosis.
Cause: Unknown
Hallmark: Philadelphia chromosome
Affects the neutrophilic or eosinophilic or clonal; arise from a hematopoietic stem cell
Elevated WBC, 5% blasts
BCR-ABL1 causes initiation of CML will be seen in peripheral smear
Weight loss, fatigue, enlarged spleen abdominal fullness, bone tenderness/pain
Peripheral smear/Bone marrow aspiration/ biopsy
Chemotherapy(Tyrosine kinase inhibitor)- Imatinib
typically, not started immediately unless WBC< 200 or the patient has symptoms such as: dyspnea, confusion, priapism, blurred vison or DVT.
TWO Types of LEUKEMIA
MYELOID AND LYMPHOCYTIC
MYELOID AFFECTS THE MYELOID CELLS -WHICH BECOME WBC, RBC AND PLTS
LYMPHOCYTIC AFFECTS THE LYMPHOCYTES (SPECIFICALLY B OR T CELLS )
AML
EPIDEMIOLOGY- OLDER ADULTS
ACUTE ONSET OF SYMPTOMS -
-Signs of anemia
-Spontaneous bleeding
-petechiae
-ecchymosis
LABS
-normocytic anema
-neutropenia
-thrombocytopenia
PBS->30% myeloblasts and has Auer rods (occur in myeloid blast cells )
CML
Epidemiology
occurs in age 25-50 years
Insidious onset of symptoms -
Mild signs of anemia
Splenomegaly
May be asymptomatic depending on level of WBC
LABS
-leukocytosis
-increased eosinophils and increased basophils
ALL
Epidemiology
-Most common form in children
S/S
acute onset of symptoms
-CNS deficiencies
labs
- Normocytic anemia
-Thrombocytopenia
-WBC variable count
-PBS-less than 30% lymphoblasts
CLL
Epidemiology -
Most common form in adults prognosis of 10 years without tx
S/S
insidious onset of symptoms
-Nonspecific fatigue and malaise
-Hepatosplenomegaly
-usually asymptomatic until end stage of disease
labs
-isolated lymphocytosis
-thrombocytopenia
-PBS-smudge cells